Who
Xiaodong Wang
Director and Other role
Company insider
Files Form 4 as: Director and Other, BeOne Medicines.
In numbers
- Trades disclosed
- 379
- Buys
- 0
- Sells
- 63
- Bought
- $0
- Sold
- $200.6M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 16 Nov 2016
- Last trade
- 13 Oct 2026
- Last filed
- 15 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Oct 2026filed 15 Oct 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Code M | $1.1M31,027 at $36.90 | filing |
| 13 Oct 2026filed 15 Oct 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $2.5M7,167 at $349.56 | filing |
| 13 Oct 2026filed 15 Oct 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $3.6M10,361 at $350.47 | filing |
| 13 Oct 2026filed 15 Oct 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $2.0M5,681 at $351.40 | filing |
| 13 Oct 2026filed 15 Oct 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $2.3M6,558 at $352.57 | filing |
| 13 Oct 2026filed 15 Oct 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $445K1,260 at $353.24 | filing |
| 13 Oct 2026filed 15 Oct 2026 | ONC BeOne Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —403,351 at $0.00 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Code M | $1.1M31,028 at $36.90 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $5.3M14,525 at $366.58 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $271K738 at $367.23 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —403,364 at $0.00 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $57K160 at $356.97 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $43K120 at $358.71 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —403,364 at $0.00 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $14K40 at $359.16 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $809K2,241 at $361.05 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $1.5M4,239 at $362.17 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $1.3M3,499 at $363.10 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $1.2M3,419 at $364.07 | filing |
| 28 Sep 2026filed 30 Sep 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $749K2,047 at $365.85 | filing |
News
Contrasting PainReform (NASDAQ:PRFX) & BeOne Medicines (NASDAQ:ONC)ONC · tickerreport.com · 21 Oct 2026Insider Selling: BeOne Medicines (NASDAQ:ONC) Insider Sells 31,027 Shares of StockONC · dailypolitical.com · 15 Oct 2026
0 headlines in the last 90 days name Xiaodong Wang; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.